Skip to content
MS
unreviewed

GPAT

0 reactions · 0 pathways

What it does, reaction by reaction

0 reactions

This enzyme appears only in the regulation table, with no catalysed step recorded.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Triacylglycerol Synthesis and Lipolysis

Accelerated by

Substrate glycerol-3-phosphate and acyl-CoA; lipogenic feeding state

Inhibited by

Limited glycerol-3-phosphate/acyl-CoA; AMPK effects on selected isoforms

Hormonal control

Insulin promotes lipogenic gene expression and substrate supply; fasting suppresses synthesis

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Responses of arbuscular mycorrhizal wheat to salinity: from symbiotic signaling to stress adaptation.

    Zamir H, Rauf F, Jamali ZH, Khan S, Zulfiqar U, Alotaibi MS, Muminov M, Abdusamatov S, Gururani MA, Korai SK. · 2026-09-23

    open access unreviewed
  2. 2
  3. 3
    Lipid metabolism in hepatopancreas and ovaries of the mud crab Scylla paramamosain during vitellogenesis.

    Zeng X, Huang C, Deng Z, Xiao Y, Zou P, Wang Y. · 2026-06-01

    unreviewed
  4. 4
    Convergent evolution of metabolic regulation governs redox adaptation in Toxoplasma.

    Giuliano CJ, Kalluraya CA, Kloehn J, Sloan MA, Bunkofske ME, Hunter CA, Soldati-Favre D, Harding CR, Lourido … · 2026-08-11

    unreviewed
  5. 5
    Genome-wide study uncovering the role of GPAT gene family in watermelon and functional validation of ClGPAT8 against cold stress.

    Aslam A, Wang X, Waseem M, Azam M, Masroor A, Shi Q, Muhammad S, Smerat A, Razzaq MK, Zhang R. · 2026-06-22

    unreviewed
  6. 6
    Tissue-resolved proteomic characterization of oat grains guided by metabolite MALDI mass spectrometry imaging.

    Lau D, Mittal P, Scanlan J, Donnellan L, Klingler-Hoffmann M, Hoffmann P. · 2026-05-11

    open access unreviewed
  7. 7
  8. 8
    Targeting osteoblast fatty acid metabolism attenuates skeletal and cardiovascular complications in chronic kidney disease models.

    Simic P, Xie H, Zhou W, Fan Y, Pereira RC, Dong F, Roh JD, Salusky IB, Singh C, Goodman RP, Khatri A, Rhee EP. · 2026-09-29

    unreviewed
  9. 9
    Astragaloside IV improves MASLD via GCN5-LXRα/SREBP1c signaling pathway-mediated hepatic de novo lipogenesis.

    Liang HM, Xu YY, Miao K, Xiao HT, Wang YD, Jin J, Wu H, Chen BY, Xu LJ, Zhu JP, Lai LN, Zheng ZG. · 2026-09-28

    open access unreviewed
  10. 10

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.